From: Prescription characteristics of phosphate binders in a high pill burden for hemodialysis patients
Model 1 | Model 2 | ||||
---|---|---|---|---|---|
Total pill burden (pills/day/patient) | Pill burden from PBs (pills/day/patient) | Total pill burden (pills/day/patient) | Pill burden from PBs (pills/day/patient) | ||
Gender (male) | β (P) | 0.097 0.040 | |||
Age (years) | β (P) | - 0.110 0.011 | - 0.250 < 0.001 | - 0.090 0.037 | - 0.255 < 0.001 |
Dialysis vintage (years) | β (P) | 0.290 < 0.001 | 0.175 < 0.001 | 0.220 < 0.001 | 0.145 0.003 |
DM (yes) | β (P) | 0.135 0.003 | 0.141 0.001 | ||
Serum P (mg/dL) | β (P) | 0.210 < 0.001 | 0.144 0.003 | 0.196 < 0.001 | 0.140 0.004 |
Oral calcimimetics (user) | β (P) | 0.175 <0.001 | 0.106 0.032 | ||
IV calcimimetics (user) | β (P) | 0.094 0.034 |